Stockscreener 앱 받기
286.74
0.39%
-1.12
시간 외 거래:
286.74
전일 마감가:
$287.86
열려 있는:
$285.77
하루 거래량:
230.74K
Relative Volume:
0.67
시가총액:
$7.67B
수익:
$2.59B
순이익/손실:
$168.80M
주가수익비율:
47.20
EPS:
6.0748
순현금흐름:
$357.20M
1주 성능:
+16.43%
1개월 성능:
-6.19%
6개월 성능:
-9.46%
1년 성능:
+25.77%
1일 변동 폭
$281.86
$290.56
1주일 범위
$242.79
$290.56
52주 변동 폭
$211.43
$343.12
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
286.74 | 7.70B | 2.59B | 168.80M | 357.20M | 6.0748 |
ABT
Abbott Laboratories
|
87.77 | 153.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.50 | 123.25B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.15 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.15 | 84.23B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.20 | 47.77B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-07 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Dow Jones Top Company Headlines at 1 AM ET: Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - Moomoo
Research Alert: CFRA Maintains Sell Rating On Shares Of Bio-rad Laboratories Inc. - Moomoo
Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption - MSN
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports - MSN
Bio-Rad cuts 2026 outlook as Amgen lifts forecast - MSN
Bio Rad Laboratories Stock Surges 11% on Reports of Activist Elliott Investment Management Stake - TIKR.com
BIO: Digital PCR growth and quality controls drive performance amid regional and market headwinds - TradingView
BIO: Digital PCR and quality controls drive growth, with margin expansion and efficiency in focus - TradingView
How Investors Are Reacting To Bio-Rad Laboratories (BIO) As RBC Sees Margin Upside Under New Leadership - Sahm
Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday - Sahm
Bio-Rad Laboratories (BIO) Stock Soars 13% on Elliott Management Investment News - GuruFocus
Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 13.8% Rally? GF Value Says Undervalued - GuruFocus
Why Elliott sees hidden billions inside Bio-Rad Laboratories - MSN
Bio-Rad (BIO) Sees Significant Stock Surge - GuruFocus
Bio-Rad rallies 13.9% as activist stake speculation lifts shares - Quiver Quantitative
BIO Stock Pops As Elliott Targets Turnaround And RBC Sees Upside - timothysykes.com
BIO Stock Jumps As Elliott Activist Stake Meets Bullish RBC Call - StocksToTrade
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories - Benzinga
Nvidia Earnings Could Decide Whether the AI Trade Still Holds - Investing.com
Research Alert: Bio-rad Laboratories Rallies On Wsj Report Of Elliott Management Stake - Moomoo
Bio-Rad (BIO) Sees 10.5% Surge in Stock Value - GuruFocus
Why Is Bio-Rad Laboratories Stock Trending Now - Kalkine Media
Elliott Builds Big Position In Bio-Rad | The Wall Street Journalnewspaper - Magzter
Bio-Rad (BIO) Faces Pressure from Activist Investor Elliott - GuruFocus
Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad -- WSJ - Moomoo
Market Chatter: Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround - Moomoo
Elliott Investment takes stake in Sartorius, Bio-Rad Laboratories By Investing.com - Investing.com Canada
BIO Stock Price, Quote & Chart | BIO-RAD LABORATORIES-A (NYSE:BIO) - ChartMill
Activist Elliott builds big stake in life-science tools supplier Bio-Rad - MSN
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports - 102.7 WBOW
Elliott builds ‘sizeable’ stake in med tech firm Bio-Rad, WSJ reports - Investing.com Nigeria
Elliott Investment Management Takes Stake in Bio-Rad Laboratories (BIO) - GuruFocus
Bio-Rad (BIO) Faces Pressure from Activist Investor - GuruFocus
Elliott Management Takes Stake in Bio-Rad to Boost Stock Performance (BIO) - GuruFocus
Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports (BIO:NYSE) - Seeking Alpha
Exclusive | Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - WSJ
Elliott builds ‘sizeable’ stake in med tech firm Bio-Rad, WSJ reports By Investing.com - Investing.com South Africa
Elliott Investment Management Has Sizable Stake in Bio-Rad Laboratories, Sources Say -- WSJ - Moomoo
Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ - Moomoo
Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449 - TradingView
Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO - TradingView
Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449 - TradingView
Bio-Rad Laboratories Inc (BIO) Stock Price, Quote, News & History - Benzinga
Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says - Moomoo
BIO Reinstated by RBC Capital -- Rating Set to Outperform with $320 Target - GuruFocus
Laboratory Proficiency Testing Market to Witness Massive - openPR.com
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
1.71%
자본화:
|
볼륨(24시간):